NYU Langone Health
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, NYU Langone Health sits in the top decile of US sponsors by registered trial count (#25 of 15,742 sponsors by registered trial count).
NYU Langone Health: 1,164 sponsored US clinical trials, 197 recruiting.
NYU Langone Health sponsors 1,164 registered US clinical trials on ClinicalTrials.gov, 197 of them currently recruiting, and 741 completed. 123 of these trials are in Phase 3-4 (later-stage) and 231 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Prostate Cancer, with 12 trials.
Top-decile sponsor footprint
NYU Langone Health ranks in the top decile of sponsors by registered trial count (#25 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
741 of 866 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (85.6%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
1,164 total, page 2 of 24
Biomarkers of Phage Treatment Response in NTM and Other Infections
NCT07076238
Neuromuscular Electrical Stimulation in Foot and Ankle Surgery
NCT06370325
The Benefits Of Cryoablation In Patients Undergoing Total Knee Arthroplasty
NCT06991231
Early Cochlear Implant Use
NCT07114744
HealthySteps + PlayReadVIP
NCT06941337
The Prevalence of Directional Preference in the Lumbar Stenosis Population
NCT07007663
Assessing Optimal XRB Initiation Points in Jail
NCT06051890
Person-Centered Quality Measurement and Management in a System for Addictions Treatment in New York State (Project 3)
NCT06408233
Improving Food Access in East Flatbush Through a Community Partner Coalition in New York City (NYC)
NCT07078253
HARP Mindfulness Study
NCT05841784
Effects of Racial Congruence, "Likes", and Food Images in Social Media Ads on Adolescents' Caloric Intake - Study 3
NCT06969651
Influence of "Likes" in Social Media Food Ads on Black and White Adolescents' Food Purchases - Study 2
NCT06969638
Building Access to Food Through Systems and Solidarity (BASIS): A Subsidized and Culturally-adapted Produce Box Program for Immigrant Communities of Brooklyn, NY
NCT07076251
Adductor Canal Block and IPACK Block vs. Isolated Adductor Canal Block for Post-Operative Analgesia Following HTO/DFO/TTO
NCT06952556
Visual Communication: Digital Tool to Improve the Understanding of Treatment Options for Patients With Cancer and Increase Satisfaction of the Overall Experience for Patients, Caregivers, and Providers
NCT06927050
A Pilot Feasibility and Acceptability Study of Remote ExerciSe Training mOdalities (PRESTO)
NCT06931470
Post-CA Neuroprotection With Magnesium
NCT06455514
Packed Red Blood Cell Transfusion During Cardiac Arrest
NCT06462027
mHealth-CArdiac REhabilitation for INOCA
NCT06829160
Effect of Internal Brace on Outcomes Following ACL Reconstruction With BTB Autograft
NCT06542705
Universal Genetic Testing for Cancer Risk Reduction
NCT06926816
Immunologic Basis of Food Protein-Induced Enterocolitis Syndrome
NCT06683521
Concurrent Azeliragon With Craniospinal Irradiation
NCT06724926
Impact of Photobiomodulation (PBM) on Biomarkers of Radiation Lymphedema and Fibrosis in Head and Neck Cancer Patients
NCT06708754
Partners in Control, Phase II: Using Remote Monitoring Technology With Community Health Workers to Support Hypertension Management for Latinx Patients
NCT06730230
Collaborative Care for Polysubstance Use in Primary Care Settings (Co-Care)
NCT06116266
An Open-Label Treatment With Randomization Observation, Investigator-Initiated Study, on the Duration and Efficacy of Jornay PM (Methylphenidate Hydrochloride Extended-Release Capsules) on Adult ADHD Symptoms and Executive Function and Emotional Regulation Throughout the Day Into Early Evening
NCT06577779
Transplanting Lungs From Uncontrolled Donation After Circulatory Death
NCT06327945
Nutritional Supplementation in Geriatric Hip Fractures
NCT06773000
Pre-operative Nutrition for Elective Resection Surgery in Inflammatory Bowel Disease
NCT06309017
Cochlear Implants and Listening Effort: the Interaction of Cognitive and Sensory Constraints
NCT07279441
Heart Rate Variability (HRV)-Guided Transcranial Direct Current Stimulation (tDCS)
NCT06455527
Leveraging Videos and Community Health Workers to Address Social Determinants of Health in Immigrants
NCT06319716
Implementing an Effective Diabetes Intervention Among Low-Income Immigrants
NCT06319703
Effect of 2-Week Continuous Glucose Monitoring on Glycemic Management in Patients New-to-Insulin on Hospital Discharge
NCT05548205
Evaluation of Tumor Control Based on Serial Multiparametric MRI and Post-Treatment Biopsies For Patients Treated With Dose Intensification to the Dominant Intra-Prostatic Lesion (DIL) Using Ultra-Hypofractionated, MR-Guided Radiotherapy
NCT06542757
Implementing Virtual Reality (VR) to Reduce Sedation
NCT06349564
Pilot Study on The Effectiveness of Relative Motion Orthosis in Finger Motion
NCT06646029
Harm Reduction Services
NCT05776316
Bridge-Enhanced ACL Repair (BEAR) in Meniscus Repair
NCT06041763
Jackson Heart Study Women's Hypertension Study
NCT06511479
Repetitive Transorbital Alternating Current Stimulation for Optic Neuropathies
NCT06662448
CD34+ Selected Stem Cell for Poor Graft Function or Graft Failure
NCT06569082
Anterior Cervical Discectomy and Fusion (ACDF) - Behavioral Intervention
NCT06520579
Clinical Evaluation of Frequency Allocation for Bimodal CI Users
NCT06663917
Fitness and Nutrition in Glioma
NCT06665373
Stress & Self-Control Costs
NCT05795179
CMV Immunity Monitoring in Lung Transplant Recipients
NCT05708755
E-Cigarettes for Harm Reduction in Smokers With Opioid Use Disorder
NCT05722561
Holistic Care Partner Program Feasibility and Acceptability
NCT06520566
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 99 |
| Phase 2 | 132 |
| Phase 3 | 28 |
| Phase 4 | 95 |
Therapeutic Areas
What is open in the NYU Langone Health pipeline
197 recruiting of 1,164 indexed (17% open); 741 completed (64%).
Phase mix: 123 late (III/IV) vs 231 early (I/II) (early-phase heavy).
Top condition: Prostate Cancer (12 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
NYU Langone Health: open-pipeline peers nationwide
Peers matched on 1,164 registered trials and 17% open enrollment, not the therapeutic-area sidebar.
NYU Langone Health sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 1,164 trials (± recruiting share)
- University of Alabama at Birmingham · 1,160 trials · 19% recruiting
- Wake Forest University Health Sciences · 1,140 trials · 15% recruiting
- Emory University · 1,208 trials · 17% recruiting
- Northwestern University · 1,209 trials · 15% recruiting
Sponsors near 17% open enrollment (± trial volume)
- CSL Behring · 17% recruiting · 71 trials
- Penn State University · 17% recruiting · 219 trials
- University of Hawaii · 17% recruiting · 77 trials
- University of Utah · 17% recruiting · 818 trials
Related
What to do with this NYU Langone Health page
1,164 registered trials is a research-attention snapshot, not an endorsement of NYU Langone Health or any single study.
- 197 of NYU Langone Health's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Prostate Cancer is the condition NYU Langone Health studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Prostate Cancer trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
NYU Langone Health pipeline card: 1,164 registered trials from official public datasets.Report a data error.